A dose–response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults
- 22 May 2007
- Vol. 25 (29) , 5367-5373
- https://doi.org/10.1016/j.vaccine.2007.05.002
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Safety and immunogenicity of a Proteosome™-trivalent inactivated influenza vaccine, given nasally to healthy adultsVaccine, 2006
- Intranasal administration of a proteosome-influenza vaccine is well-tolerated and induces serum and nasal secretion influenza antibodies in healthy human subjectsVaccine, 2006
- Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccineVaccine, 2004
- Immunization against Influenza: Comparison of Various Topical and Parenteral Regimens Containing Inactivated and/or Live Attenuated Vaccines in Healthy AdultsThe Journal of Infectious Diseases, 2001
- Correlates of Immune Protection Induced by Live, Attenuated, Cold‐Adapted, Trivalent, Intranasal Influenza Virus VaccineThe Journal of Infectious Diseases, 2000
- Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multi-centre, dose—response study in elderly nursing-home residents and young volunteersVaccine, 1993
- Improvement of the immunoglobulin subclass response to influenza vaccine in elderly nursing-home residents by the use of high-dose vaccinesVaccine, 1993
- Humoral and secretory antibody responses to immunization with low and high dosage split influenza virus vaccineArchiv für die gesamte Virusforschung, 1975
- Human Influenza: Aspects of the Immune Response to VaccinationAnnals of Internal Medicine, 1969
- Influenza Antibody in Human Respiratory Secretions after Subcutaneous or Respiratory Immunization with Inactivated VirusNature, 1968